JSP: Lannett Set to Lose Distribution Agreement With Key Supplier
Lannett Company's (LCI) distribution agreement with key supplier, Jerome Stevens Pharmaceuticals, not to be renewed on expiry. Shares plunge.
Read full article »
CEO
JSP is a pharmaceutical company that develops and commercializes drugs for the treatment of thyroid tumors.
Read more